Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Neurology
»
Parkinson
07. September 2026
Search
medline.ch
Parkinson
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Alzheimer
Epilepsy
Infections
Headache
Multiple Sclerosis
Neoplasms
Neuromuscular Diseases
Parkinson
Cerebrovascular Diseases
CNS Trauma
Others
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 2938
Articles 1 - 20 / 58743
Drug Repurposing for Parkinson's Disease Prevention: Replication Study of Three Drugs in French Healthcare Databases.
Mov Disord
Saidi Y, Paakinaho A, Pylkkö E, Hartikainen S, Tolppanen AM, Elbaz A, Ahmed I, Thiébaut ACM, Courtois É.
PMID: 42703031 [PubMed - as supplied by publisher]
Convergent Vulnerability and Divergent Outcomes of the Dopaminergic System in Parkinson's and Alzheimer's Diseases.
Ageing Res Rev
Xi YT, Jia CX, Wang HD, Liu PY, Li P, Niu Q, Yin YL.
PMID: 42702294 [PubMed - as supplied by publisher]
A curriculum-guided unified framework for robust unsupervised domain adaptation on multi-cohort Parkinson's disease diagnosis.
Quant Imaging Med Surg
Shen Y, Hai J, Qiao K, Chen J, Li Y, Yan B.
PMID: 42701495 [PubMed]
Comparative Effectiveness of Cognitive Behavioral Therapy Delivery Formats on Anxiety, Depression, and Quality of Life in Parkinson's Disease: A Network Meta-Analysis.
Am J Geriatr Psychiatry
Li T, Zhang S, Ding X, Zhu M, Chen H, Luo Z, Wei W, Li Z.
PMID: 42701077 [PubMed - as supplied by publisher]
Physical Training in Parkinson's Disease: A Systematic Review of Neurobiological Mechanisms, Brain-Muscle Adaptations, and Implications for Personalized Rehabilitation.
Neurodegener Dis
Jannou A, Welter ML.
PMID: 42700415 [PubMed - as supplied by publisher]
Art, neuroplasticity, and tradition: a narrative review and conceptual perspective of Chinese woodblock printing in global art practices and Parkinson's disease neuroscience.
Front Neurosci
Lin K, Fang Q, Li K.
PMID: 42698827 [PubMed]
Unveiling the Distinctive Brain Functional Dynamics Between Parkinson's Disease and Progressive Supranuclear Palsy.
CNS Neurosci Ther
Ye C, Shi J, Fang J, Wu T, Chan P, Ma J, Ma T.
PMID: 42698292 [PubMed - indexed for MEDLINE]
Characteristics and Hospitalization Details of Patients with Advanced Parkinson's Disease Receiving Continuous Subcutaneous Infusion of Foslevodopa/Foscarbidopa: Real-World First-Year Descriptive Study from Japan.
Neurol Ther
Baba T, Nozaki T, Toya S, Migita H, Ri K, Takeda A.
PMID: 42698056 [PubMed - as supplied by publisher]
Antibiotics and nanoparticles in Parkinson's disease: From gut microbiota dysbiosis to neuroprotection and targeted nanotherapies.
Biomed Pharmacother
Frangieh MR, Saad M, Fattouh N, Sawan S.
PMID: 42697040 [PubMed - as supplied by publisher]
Effects of immersive gamification technology on the physical function of people with Parkinson's disease: a scoping review.
J Neural Transm (Vienna)
Aguila MER, Guitones KIM, Arellano MYB, Rivera MB, Evangelista IMB, Tanglao MJB, Ting JRP, Rabano AJ, Cruz CAK, Lopez BAA, Caro JDL, Tee ML, Tee CA, Anlacan VMM, Jamora RDG.
PMID: 42696108 [PubMed - as supplied by publisher]
Development and clinical translation of smartphone-based digital biomarkers for Parkinson's disease: a structured review.
J Neural Transm (Vienna)
Phokaewvarangkul O, Yamutai S, Bhidayasiri R, Vateekul P, Surangsrirat D, Maetzler W, Pilotto A, Shin C, Oyama G.
PMID: 42696106 [PubMed - as supplied by publisher]
Protocols for Bedside Assessment of Autonomic Dysfunction in Parkinson's Disease and Multiple System Atrophy.
J Vis Exp
Mori Y, Yamahara N, Ando T, Ono Y, Kato M, Ito M, Kodama M, Kanazumi S, Shimohata T.
PMID: 42695590 [PubMed - indexed for MEDLINE]
Glycolytic Reprogramming in Parkinson's Disease: From Bioenergetic Crosstalk to Therapeutic Modulation.
Med Res Rev
Yi Y, Chen C, He Y, Sun YZ, Cheng R, Liu MX, Liu ZG, Zhang XL.
PMID: 42695230 [PubMed - as supplied by publisher]
A Systematic Review of Health Literacy in People Living With Parkinson's Disease.
Health Sci Rep
Mahomed-Kola S, Watermeyer J, Ferreira-Correia A.
PMID: 42694571 [PubMed]
Bibliometric Analysis of Research Trends and Key Areas Related to the Relationship Between Parkinson's Disease and Exercise Therapy.
Parkinsons Dis
Fang Z, Zeng S, Xu D, Liu H.
PMID: 42694491 [PubMed]
Individual differences in set-shifting and levodopa responsiveness in Parkinson's disease.
J Neuropsychol
Fija, Batko K, Dec-, Por, B, Gruszka A.
PMID: 42693748 [PubMed - as supplied by publisher]
Activity contextualisation and terrain classification via wearables in Parkinson's.
Comput Methods Programs Biomed
Engin FV, Kuduz H, Kacar F, Pearson-Noseworthy LT, Das J, Stuart S, Woo WL, Godfrey A, Celik Y.
PMID: 42691756 [PubMed - as supplied by publisher]
The Worldwide Burden of Parkinson's Disease Is Growing, but Its Incidence Is Not: Lessons from Population-Based Studies.
Mov Disord
Urso D, Ben-Shlomo Y, Logroscino G, Schrag A.
PMID: 42689419 [PubMed - as supplied by publisher]
Recent medicinal chemistry efforts of targeting protein kinases for treating neurological conditions of Parkinson's and Alzheimer's diseases.
RSC Adv
Kaur R, Lang DK, Sood A, Singh TG, Chandrasekaran B, Al-Sha'er MA.
PMID: 42689220 [PubMed - as supplied by publisher]
Shared Metabolic-Proteinopathy Axis in Alzheimer's Disease and Parkinson's Disease: Evidence for a Convergent but Not Identical Disease Spectrum.
Aging Med (Milton)
Yao SY, Du MQ, Lin LX, Kang XH, Jiang DY, Peng Y.
PMID: 42688951 [PubMed - as supplied by publisher]
Articles 1 - 20 / 58743
Page 1 of 2938
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy